Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Industry Pipeline
Pre-Interphex 2010 Product Releases.
Mar 2, 2010
Pharmaceutical Technology
Volume 34, Issue 3, pp. 83-87
« Previous
1234567891011
Next »

PACKAGING EQUIPMENT & SUPPLIES



Brand-protection technology
NanoEncryption technology is on-dose brand-protection technology that enables manufacturers to trace and authenticate every dose from plant to patient. The technology possesses security features at the overt, covert, and forensic levels and can be applied directly to tablets, capsules, and vial caps. NanoGuardian, Skokie, IL • http://www.nanoink.net/ • tel. 847.679.6266



Packaging solution
The NextBottle package from Catalent and One World Design and Manufacturing Group is designed to improve patient compliance. The product's dial mechanism dispenses one pill at a time and automatically reminds patients of the last day that a pill was taken. Catalent Pharma Solutions, Somerset, NJ • http://www.catalent.com/ • tel. 866.720.3148



Integrated blister line
The Giant1 integrated blister line fully responds to sophisticated production requirements worldwide. The line is an alternative for the timely production of small and medium-sized batches. The unit produces as many as 350 blisters/min and 175 cartons/min. The machine provides flexible operation and changeover and easy cleaning. IMA Group, Bristol, PA • http://www.ima.it/ • tel. 215.826.8500

« Previous
1234567891011
Next »

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
75%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology, 3/2/2010
 Click here